Literature DB >> 17151506

Intravitreal triamcinolone acetonide for treatment of cystoid macular edema associated with retinitis pigmentosa.

Judy E Kim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17151506     DOI： 10.1097/01.iae.0000254897.86389.a5

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  5 in total

1.  Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.

Authors:  Buğra Karasu
Journal:  Int Ophthalmol       Date:  2019-11-26       Impact factor: 2.031

2.  Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date.

Authors:  Francesco Parmeggiani; Giovanni Sato; Katia De Nadai; Mario R Romano; Andrea Binotto; Ciro Costagliola
Journal:  Curr Genomics       Date:  2011-06       Impact factor: 2.236

Review 3.  Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention.

Authors:  S Strong; G Liew; M Michaelides
Journal:  Br J Ophthalmol       Date:  2016-12-02       Impact factor: 4.638

4.  Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa.

Authors:  Nurgül Örnek; Kemal Örnek; İnci Elif Erbahçeci
Journal:  Turk J Ophthalmol       Date:  2016-08-15

5.  Bilateral intravitreal dexamethasone implant for retinitis pigmentosa-related macular edema.

Authors:  Ali Osman Saatci; Ozlem Barut Selver; Goktug Seymenoglu; Aylin Yaman
Journal:  Case Rep Ophthalmol       Date:  2013-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.